116 related articles for article (PubMed ID: 19574641)
1. Crystallization and preliminary crystallographic studies of the single-chain variable fragment of antibody chA21 in complex with an N-terminal fragment of ErbB2.
Liu Y; Zhou H; Zhu J; Gao Y; Niu L; Liu J; Teng M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):692-4. PubMed ID: 19574641
[TBL] [Abstract][Full Text] [Related]
2. [Characterization and analysis of the aggregation of a single-chain chimeric anti-ErbB2 antibody].
Zhu J; Rong Z; Jiang B; Liu J
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1918-23. PubMed ID: 19256339
[TBL] [Abstract][Full Text] [Related]
3. Structural insight into a matured humanized monoclonal antibody HuA21 against HER2-overexpressing cancer cells.
Wang Z; Cheng L; Guo G; Cheng B; Hu S; Zhang H; Zhu Z; Niu L
Acta Crystallogr D Struct Biol; 2019 Jun; 75(Pt 6):554-563. PubMed ID: 31205018
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the down-regulation of overexpressed p185(her2/neu) protein of transformed cells by the antibody chA21.
Zhou H; Zha Z; Liu Y; Zhang H; Zhu J; Hu S; Shen G; Cheng L; Niu L; Greene MI; Teng M; Liu J
J Biol Chem; 2011 Sep; 286(36):31676-83. PubMed ID: 21680730
[TBL] [Abstract][Full Text] [Related]
6. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.
Franklin MC; Carey KD; Vajdos FF; Leahy DJ; de Vos AM; Sliwkowski MX
Cancer Cell; 2004 Apr; 5(4):317-28. PubMed ID: 15093539
[TBL] [Abstract][Full Text] [Related]
7. [Eukaryotic expression and biological activities of anti-p185 erbB2 mouse/human chimeric antibody].
Jiang BH; Liu WB; Meng L; Wu J; Shou CC
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):491-5. PubMed ID: 15489929
[TBL] [Abstract][Full Text] [Related]
8. Crystallization and preliminary crystallographic analysis of the N-terminal two domain fragment of vascular cell adhesion molecule-1 (VCAM-1).
Wang J; Pepinsky B; Karpusas M; Liu J; Osborn L
Proteins; 1994 Nov; 20(3):287-90. PubMed ID: 7534402
[TBL] [Abstract][Full Text] [Related]
9. Purification, crystallization and preliminary crystallographic analysis of histone lysine demethylase NO66 from Homo sapiens.
Zhou X; Tao Y; Wu M; Zhang D; Zang J
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jul; 68(Pt 7):764-6. PubMed ID: 22750859
[TBL] [Abstract][Full Text] [Related]
10. Preliminary X-ray analysis of a human V(H) fragment at 1.8 A resolution.
Gaur RK; Kupper MB; Fischer R; Hoffmann KM
Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):965-7. PubMed ID: 15103154
[TBL] [Abstract][Full Text] [Related]
11. Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics.
Smirnov I; Carletti E; Kurkova I; Nachon F; Nicolet Y; Mitkevich VA; Débat H; Avalle B; Belogurov AA; Kuznetsov N; Reshetnyak A; Masson P; Tonevitsky AG; Ponomarenko N; Makarov AA; Friboulet A; Tramontano A; Gabibov A
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15954-9. PubMed ID: 21896761
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary crystallographic analysis of tRNA (m(7)G46) methyltransferase from Escherichia coli.
Liu Q; Gao Y; Yang W; Zhou H; Gao Y; Zhang X; Teng M; Niu L
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Aug; 64(Pt 8):743-5. PubMed ID: 18678947
[TBL] [Abstract][Full Text] [Related]
13. Production, crystallization and preliminary crystallographic analysis of an exosite-containing fragment of human von Willebrand factor-cleaving proteinase ADAMTS13.
Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):739-42. PubMed ID: 19574655
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
[TBL] [Abstract][Full Text] [Related]
15. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
16. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
Essen LO; Skerra A
J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
[TBL] [Abstract][Full Text] [Related]
17. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment.
Willuda J; Honegger A; Waibel R; Schubiger PA; Stahel R; Zangemeister-Wittke U; Plückthun A
Cancer Res; 1999 Nov; 59(22):5758-67. PubMed ID: 10582696
[TBL] [Abstract][Full Text] [Related]
18. Codon optimization, expression, and characterization of an internalizing anti-ErbB2 single-chain antibody in Pichia pastoris.
Hu S; Li L; Qiao J; Guo Y; Cheng L; Liu J
Protein Expr Purif; 2006 May; 47(1):249-57. PubMed ID: 16403645
[TBL] [Abstract][Full Text] [Related]
19. Crystallization and preliminary X-ray diffraction study of an idiotope-anti-idiotope Fv-Fv complex.
Goldbaum FA; Fields BA; Cauerhff A; Ysern X; Houdusse A; Eisele JL; Poljak RJ; Mariuzza RA
J Mol Biol; 1994 Sep; 241(5):739-43. PubMed ID: 8071997
[TBL] [Abstract][Full Text] [Related]
20. Crystallization and preliminary X-ray crystallographic analysis of the sclerostin-neutralizing Fab AbD09097.
Boschert V; Muth EM; Knappik A; Frisch C; Mueller TD
Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):388-92. PubMed ID: 25849496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
